High dosage valbenazine formulation and compositions, methods, and kits related thereto | Patent Publication Number 20210030744

US 20210030744 A1
Patent NumberUS 11311532 B2
Application Number17074383
Filled DateOct 19, 2020
Priority DateSep 21, 2017
Publication DateFeb 4, 2021
Original AssigneeNeurocrine Biosciences
Current AssigneeNeurocrine Biosciences
Inventor/ApplicantsRichard Alexander Moore, JR.
Christopher F. O'Brien
Christopher F. O`Brien
Gregory A. McClelland
Richard Alexander Moore, Jr.
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.